Guardant Health, Inc. (GH)

NMS – Real vaqt narxi. Valyuta: USD

165.16

+0.07 (0.04%)

Yopilishda: Aug 12, 2026, 3:59 PM EDT

165.15

+0.04 (0.02%)

Bozordan keyin: Aug 12, 2026, 4:57 PM EDT

11.08.2026

Guardant Health: Screening And MRD Are Just Getting Started

Guardant Health is experiencing robust growth, driven by its MRD and screening businesses. Recent FDA approvals, expanded reimbursement, and inclusion in clinical guidelines should help to ensure growth remains strong going forward. Competition in both screening and MRD monitoring is set to intensify in coming years, though.

10.08.2026

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on July 21, 2026, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units (“RSUs”) representing 46,044 shares of its common stock to 149 new non-executive employees with a grant date of August 3, 2026, under the Guardant Health, Inc. 2023 Employment Inducement Incentive Award Plan (the “Inducement Plan”). The RSUs.

06.08.2026

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

Nebius Group, Credo Technology Group, and Guardant Health, Inc. were among the top contributors to performance. During the quarter, Credo shares contributed positively to performance as investors responded favorably to the company's rapid revenue growth and rising demand from hyperscale customers. Karman Holdings Inc., GeneDx Holdings Corp., and Forte Biosciences Inc. were among the top detractors from performance.

01.08.2026

GE Aerospace, AI Play Lead Five Stocks Near Buy Points

Three of these watchlist stocks have already passed their earnings tests.

31.07.2026

Biotech company launches multi-cancer detection test

Guardant Health co-founder and co-CEO Helmy Eltoukhy discusses his company's blood test for colorectal cancer on ‘The Claman Countdown.'

Videolar

31.07.2026

Positive

Biotech company launches multi-cancer detection test

Press-relizlar

10.08.2026

Guardant Health, Inc. (GH)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Guardant Health, Inc. (GH)

Guardant Health: Screening And MRD Are Just Getting Started

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

GE Aerospace, AI Play Lead Five Stocks Near Buy Points

Biotech company launches multi-cancer detection test

Videolar

Press-relizlar

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Guardant Health: Screening And MRD Are Just Getting Started

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

GE Aerospace, AI Play Lead Five Stocks Near Buy Points

Biotech company launches multi-cancer detection test

Videolar

Press-relizlar

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Search stocks

Guardant Health, Inc. (GH)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Guardant Health, Inc. (GH)

Guardant Health: Screening And MRD Are Just Getting Started

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

GE Aerospace, AI Play Lead Five Stocks Near Buy Points

Biotech company launches multi-cancer detection test

Videolar

Press-relizlar

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Guardant Health: Screening And MRD Are Just Getting Started

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

GE Aerospace, AI Play Lead Five Stocks Near Buy Points

Biotech company launches multi-cancer detection test

Videolar

Press-relizlar

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)